BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 30, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» PA2G4-MYC signaling axis involved in pathogenesis of 3q26 AML, study shows
To read the full story,
subscribe
or
sign in
.
Cancer
PA2G4-MYC signaling axis involved in pathogenesis of 3q26 AML, study shows
June 26, 2024
No Comments
The treatment of subtypes of acute myeloid leukemia (AML) characterized by aberrantly activated transcription factors is still challenging.
BioWorld Science
Conferences
European Hematology Association
Cancer